BACKGROUND: Chronic infection with hepatitis B virus and hepatitis delta virus (HDV) results in the most severe form of viral hepatitis. There is no currently approved treatment. We investigated the safety and efficacy of 48 weeks of treatment with peginterferon alfa-2a plus adefovir dipivoxil, pegi
HGV2009 meeting: bigger and better studies provide more answers and more questions
โ Scribed by Katherine Reekie; Andres Metspalu; Stephen J. Chanock; Edison T. Liu; Elaine R. Mardis; Stephen W. Scherer; Pui-Yan Kwok; Anthony J. Brookes
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 98 KB
- Volume
- 31
- Category
- Article
- ISSN
- 1059-7794
No coin nor oath required. For personal study only.
โฆ Synopsis
The 11th International Meeting on Human Genome Variation and Complex Genome Analysis (HGV2009: Tallinn, Estonia, 11th-13th September 2009) provided a stimulating workshop environment where diverse academics and industry representatives explored the latest progress, challenges, and opportunities in relating genome variation to evolution, technology, health, and disease. Key themes included Genome-Wide Association Studies (GWAS), progress beyond GWAS, sequencing developments, and bioinformatics approaches to large-scale datasets.
๐ SIMILAR VOLUMES